Vitamin D K2 & Zinc

Vitamin D K2 & Zinc

Amen4.8 (748 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals

About this product

Bone and mineral nutrition is the most coherent use for the main combination. Vitamin D supports calcium absorption when intake or status is low, while MK-7 helps activate proteins involved in bone health. The 125 mcg vitamin D serving does not establish greater benefit simply because it is high.

MK-7 is clearly identified at 90 mcg, although its trans or all-trans composition is not specified. Its bone and arterial-stiffness findings have limits and do not establish broad protection from the D3 and K2 combination. Zinc at 30 mg adds normal immune and skin-related nutritional support, with hair and testosterone relevance mainly tied to inadequate zinc intake.

The main nutrient amounts are easy to compare, and value appears reasonable for MK-7 and zinc. The zinc chelate is broadly named, copper information is unavailable, and the whole-food blend does not identify its individual contents. Those gaps leave the mineral balance and the blend's added contribution uncertain.

Who is it for
  • Adults with a reviewed need for higher vitamin D intake
  • People seeking MK-7 with zinc and willing to check their full supplement intake
Best for
  • Bone and mineral nutrition when intake or status is low
  • A clearly quantified MK-7 contribution

Pros

  • States the MK-7 subtype and amount
  • Clearly quantifies the main three nutrients
  • Reasonable value for the zinc and MK-7 contributions

Cons

  • Whole-food blend components are undisclosed
  • Copper information is unavailable alongside 30 mg zinc
  • Zinc chelate carrier and MK-7 isomer details are incomplete
  • Additional heart or hormone benefits from the combination remain unestablished

Warnings

  • The 125 mcg vitamin D serving warrants review before ongoing daily use, particularly if another supplement also contains vitamin D.
  • Adding separate zinc to the 30 mg already supplied can make total zinc intake excessive.

Product analysis

60 out of 100

Vitamin D K2 & Zinc supplies nutrients for normal immune, bone and mineral functions, with benefits most relevant when intake is inadequate. Its unidentified herbal blend makes that part of the formula difficult to judge.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality53

MK-7 is the clearest strength among the nutrient forms. Zinc has less convincing form-quality support, while the vitamin D comparison and herbal blend details remain uncertain.

Ingredient Transparency73

The nutrient amounts and vitamin and zinc forms are disclosed. The herbal blend contents and form are undisclosed, so its total amount does not show what each plant contributes.

Value For Money62

MK-7 offers favorable value at the full serving cost, with zinc providing more moderate value. Vitamin D value remains uncertain, so the combination cannot be judged equally across all its nutrients.

Customer Satisfaction81

Customer satisfaction is very positive across several hundred ratings. The response volume provides a useful view of buyer experience without establishing health benefits.

Product Focus35

Normal immune and bone functions provide the clearest nutritional purpose. The wider goals have more conditional support, and the unidentified herbal blend prevents a complete view of the formula.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.38
Customer rating
4.8 · 748 ratings
Report analysis

Goals

Immunity
Impact
Highest effect
B+ Ingredient FitA+ PathwaysA+ EvidenceA+ Formulation Logic
Zinc · 30 mgVitamin D · 125 mcg

Zinc and vitamin D support normal immune-cell function. Both receive full recognition for their declared amounts in the saved findings, but this does not establish infection prevention or greater benefit from the higher vitamin D amount. Elderberry presence remains unresolved in the supplied inventory, so it cannot support a product-specific contribution.

How this product is rated for Immunity

Ingredient fit83

The formula’s immune connection comes from its relevant nutrients, with amount and focus limitations reflected below.
Goal fit
Relevant nutrients share the formula with ingredients serving other goals, reducing its focus on immunity.
Dose adequacy
The declared amounts fully meet the saved comparisons; larger amounts do not imply greater immune benefit.

Pathways100

The strongest saved coverage concerns lymphocyte function and immune regulation.
Depth
The strongest saved finding concerns lymphocyte function and immune regulation; this describes supported coverage rather than infection protection.
Breadth
The saved findings cover barrier and antimicrobial defense, innate immune cell activity, lymphocyte function and immune regulation.

Evidence100

Zinc anchors the strongest recognized evidence; the supplied context limits what clinical benefits can be inferred.
Evidence strength
Zinc provides the strongest recognized evidence here; its benefit remains bounded by the supplied nutritional or regular-use findings.
Studied preparation
The saved findings accept the recognized forms at qualifying amounts; this does not establish that one form provides greater clinical benefit.

Formulation logic100

The recognized ingredients have no missing required partner or configured conflict.
Partner coverage
The recognized ingredients need no missing partner for their assigned contributions.
Conflicts
No configured ingredient conflict was found; this is not a full assessment of suitability.
Effective doses
All recognized ingredients meet the saved minimum amount comparison; that threshold is not proof of clinical effectiveness.
Study evidence
Vitamin D Supportive 85 studies
Zinc Supportive 73 studies
Everyday Health
Impact
Highest effect
B+ Ingredient FitB+ PathwaysB+ EvidenceA+ Formulation Logic
Vitamin D · 125 mcgVitamin K · 90 mcgZinc · 30 mg

Vitamins D and K provide nutrients relevant to bone and mineral health, while zinc adds a nutritional contribution when intake is inadequate. These roles do not establish enhanced immunity, cardiovascular protection or extra benefit from combining the nutrients. The unresolved elderberry record cannot establish an additional contribution.

How this product is rated for Everyday Health

Ingredient fit84

The included ingredients are focused on the supplied nutritional or general-health roles. Declared amounts provide partial coverage of the saved comparisons; this concerns nutrient availability rather than a proven clinical response.
Goal fit
The included ingredients are focused on the supplied nutritional or general-health roles.
Dose adequacy
Declared amounts provide partial coverage of the saved comparisons; this concerns nutrient availability rather than a proven clinical response.

Pathways80

The strongest connection is bone and mineral metabolism. This describes the main supplied functional connection. The findings span two functional areas, indicating broader coverage without establishing added benefit from combining ingredients.
Depth
The strongest connection is bone and mineral metabolism. This describes the main supplied functional connection.
Breadth
The findings span two functional areas, indicating broader coverage without establishing added benefit from combining ingredients.

Evidence82

The saved findings recognize evidence and preparation matches for the included ingredients. Nutritional availability and narrower outcomes do not establish routine broad health improvement.
Evidence strength
Vitamin D leads the saved evidence comparison; its nutritional or indication-specific evidence does not establish broad benefits above adequate status.
Studied preparation
Included preparations matched the saved comparison, without establishing superiority of delivery or chemical form.

Formulation logic100

Included ingredients had no missing required partners or configured conflicts and reached the saved minimum amount threshold.
Partner coverage
No required partner was missing among the included ingredients; this does not establish synergy.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All included ingredients reached the saved minimum amount threshold; excluded low amounts are not necessarily nutritionally worthless.
Study evidence
Vitamin D Supportive 115 studies
Vitamin K Supportive 34 studies
Zinc Supportive 60 studies
Cardiovascular Support
Impact
Moderate effect
B- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Vitamin K · 90 mcgVitamin D · 125 mcg

Vitamin D K2 & Zinc provides 125 mcg vitamin D and 90 mcg vitamin K as MK-7. Those nutrients link mainly to calcium buildup in artery walls rather than a broad set of cardiovascular markers; the added zinc has no clear marker link in the supplied context. These ingredient links don't establish heart-event prevention.

How this product is rated for Cardiovascular Support

Ingredient fit71

Vitamin D and K2 are the two cardiovascular-linked actives, both with declared amounts. Zinc doesn't add a clear marker link, and the product is connected to several other goals.
Goal fit
Vitamin D and K2 connect to cardiovascular markers; zinc and the product's other goal links dilute the focus.
Dose adequacy
Vitamin D at 125 mcg and vitamin K at 90 mcg have declared amounts that support meaningful dose alignment.

Pathways16

Calcium buildup in artery walls is the clearest route, with moderate rather than broad coverage. Other cardiovascular pathways have little support from the disclosed actives.
Depth
Calcium buildup in artery walls is the clearest route, but coverage remains moderate.
Breadth
No second pathway has enough support to add meaningful marker coverage.

Evidence69

Vitamin K provides the clearest supplied evidence link, while vitamin D also contributes. The evidence concerns markers, not cardiovascular events.
Evidence strength
Vitamin K has the clearest supplied effective-dose evidence among the credited ingredients.
Studied preparation
The MK-7 and cholecalciferol forms correspond to preparations in the supplied evidence.

Formulation logic100

Both credited ingredients can contribute without a required partner, and no conflict trigger is identified. Their amounts reach useful dose ranges.
Partner coverage
Vitamin D and K2 can each contribute without a required partner.
Conflicts
No caffeine, stimulant, or high-sodium conflict trigger is identified in the supplied facts.
Effective doses
Both vitamin D and K2 reach useful portions of their dose references.
Study evidence
Vitamin D Mixed 170 studies
Vitamin K Supportive 40 studies
Bone Health
Impact
Highest effect
B+ Ingredient FitA+ PathwaysA+ EvidenceA Formulation Logic
Vitamin K · 90 mcgVitamin D · 125 mcgZinc · 30 mg

Vitamin D supports calcium absorption and deficiency-related mineralization, while MK-7 helps activate bone proteins. MK-7 bone-density findings are limited to specific postmenopausal populations and do not establish fracture prevention. The 125 mcg vitamin D serving does not establish extra benefit over nutritional adequacy. Zinc is included in the saved findings, but the supplied evidence does not establish routine additional adult bone-density or fracture benefit from zinc supplementation.

How this product is rated for Bone Health

Ingredient fit85

The formula includes nutrients connected to bone health, with differing serving contributions and preparation-specific limitations.
Goal fit
The included ingredients are focused on bone-related roles, although the product is linked to several goals.
Dose adequacy
The declared serving amounts provide uneven contributions relative to the supplied comparison amounts; unknown amounts cannot establish an additional contribution.

Pathways100

The saved findings emphasize calcium absorption and regulation and show broader coverage through calcium handling, bone-protein activation and collagen matrix formation. Coverage describes ingredient roles, not demonstrated clinical improvement.
Depth
The strongest saved finding concerns calcium absorption and regulation; this describes ingredient roles rather than a measured clinical outcome.
Breadth
The saved findings reach the comparison level for calcium handling, bone-protein activation and collagen matrix formation.

Evidence98

MK-7 leads the saved evidence finding, with limited postmenopausal bone-density evidence rather than established fracture prevention.
Evidence strength
MK-7 leads the saved evidence finding, with limited postmenopausal bone-density evidence rather than established fracture prevention.
Studied preparation
The saved findings recognize the included forms as studied; this does not establish that the finished product has demonstrated bone outcomes.

Formulation logic95

Vitamin D lacks the full partner support required by the saved combination finding; its own nutritional role remains relevant. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
Vitamin D lacks the full partner support required by the saved combination finding; its own nutritional role remains relevant.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All ingredients counted in this finding meet the saved amount threshold; that threshold is not proof of clinical benefit.
Study evidence
Vitamin D Supportive 202 studies
Vitamin K Supportive 78 studies
Zinc Supportive 33 studies
Heart Health
Impact
Moderate effect
C+ Ingredient FitF PathwaysB EvidenceA+ Formulation Logic
Vitamin K · 90 mcgVitamin D · 125 mcg

The 90 mcg MK-7 serving relates to the limited human findings on arterial stiffness. Vitamin D contributes to nutrient intake, while a combined D3/K2 heart-health benefit is not assumed from their presence together.

How this product is rated for Heart Health

Ingredient fit70

2 ingredients relate to this goal, alongside 1 actives aimed at other needs. The relevant amounts provide substantial support within the saved comparison.
Goal fit
2 ingredients relate to this goal, alongside 1 actives aimed at other needs.
Dose adequacy
The relevant amounts provide substantial support within the saved comparison.

Pathways16

Arterial calcification control is the strongest mechanism in the saved assessment, with limited coverage. 0 of the three target mechanisms meets the saved coverage level.
Depth
Arterial calcification control is the strongest mechanism in the saved assessment, with limited coverage.
Breadth
0 of the three target mechanisms meets the saved coverage level.

Evidence77

Vitamin K provides the strongest evidence contribution among the assessed amounts. This remains specific to the supplied evidence and its context.
Evidence strength
Vitamin K provides the strongest evidence contribution among the assessed amounts. This remains specific to the supplied evidence and its context.
Studied preparation
The assessed contribution matches preparations recognized in the saved assessment.

Formulation logic100

All 2 assessed ingredients meet the saved amount threshold. No conflict was recorded by the supplied checks.
Partner coverage
The assessed ingredients can work alone or have their required partners present.
Conflicts
No conflict was recorded by the supplied checks.
Effective doses
All 2 assessed ingredients meet the saved amount threshold.
Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
Testosterone Support
Impact
High effect
B+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Zinc · 30 mgVitamin D · 125 mcg

Zinc helps maintain testosterone when low zinc intake is a limiting factor; extra increases are not established when zinc intake is adequate. Vitamin D has limited findings in initially deficient men, without an established testosterone increase in nutrient-replete users.

How this product is rated for Testosterone Support

Ingredient fit83

Relevant nutritional ingredients are present, with the amount findings determining how much they contribute.
Goal fit
Relevant nutrients are accompanied by ingredients serving broader purposes.
Dose adequacy
The amounts meet the supplied comparison anchors, without establishing an effective testosterone-boosting dose.

Pathways0

No direct coverage of the evaluated hormone processes was found.
Depth
No direct coverage of the evaluated hormone processes was found.
Breadth
None of the evaluated hormone processes reaches the supplied coverage requirement.

Evidence93

Zinc has the strongest relevant support for correcting low-zinc-related testosterone impairment.
Evidence strength
Zinc has the strongest relevant support for correcting low-zinc-related testosterone impairment.
Studied preparation
The relevant declarations are accepted for comparison, without establishing equivalent hormone outcomes for this product.

Formulation logic100

No configured ingredient conflict was found. All counted ingredients meet the minimum amount comparison, which is not a proven hormone-enhancing dose.
Partner coverage
No required ingredient partner is missing in the supplied findings.
Conflicts
No configured ingredient conflict was found.
Effective doses
All counted ingredients meet the minimum amount comparison, which is not a proven hormone-enhancing dose.
Study evidence
Vitamin D Supportive 56 studies
Zinc Disputed 7 studies

Ingredients

IngredientAmount per servingScore
Vitamin D3 (Cholecalciferol)
125 mcg
Zinc (Zinc Amino Acid Chelate)
30 mg 55
Organic Whole Food Blend
100 mg
Vitamin K2 (Menaquinone-7)
90 mcg 93
Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
B+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value
Each serving provides 90 mcg of vitamin K2 as MK-7. The evaluation considers the amount well aligned; a whole-product serving costs about $0.38.
How this ingredient is rated

Active Ingredient Quality & Bioavailability82

Vitamin K is present as MK-7, a form that can remain in the bloodstream longer than other forms. The saved information does not specify whether it is the trans form.
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
Vitamin K2 is present as MK-7, which can remain in the bloodstream longer than other vitamin K forms.
MK-7 Isomer Disclosure
The stored information identifies MK-7 but does not specify a trans or all-trans isomer.

Dose, Safety & Label Transparency100

The amount and subtype are identified: 90 mcg of MK-7 per serving, an amount the evaluation considers well aligned.
Vitamin K2 (MK-7) Dosage Efficacy
The serving provides 90 mcg of MK-7, an amount the evaluation considers well aligned.
Form and Subtype Transparency
The amount and subtype are identified as 90 mcg of MK-7 per serving.

Value100

A whole-product serving costs about $0.38.
Price per Effective MK-7 Serving
The price is about $0.38 per whole-product serving.
D- Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyC Value
The serving provides 30 mg of zinc as zinc amino acid chelate. The copper amount is unknown, so the zinc-to-copper balance cannot be assessed.
How this ingredient is rated

Active Ingredient Quality & Bioavailability40

The zinc is described as an amino acid chelate; the specific chelate is not identified in the available information.
Zinc Form Bioavailability
The broadly named amino acid chelate leaves its precise form unclear in the available information.

Dose, Safety & Label Transparency67

The serving provides 30 mg of zinc; the copper amount is unknown.
Elemental Dose Transparency
The zinc amount is stated as 30 mg per serving, and its source is identified.
Zinc Dosage Safety & Effectiveness
30 mg is a substantial amount of zinc per serving.
Zinc-to-Copper Mineral Balance
The copper amount is unknown, so the zinc-to-copper ratio cannot be determined.

Value60

The whole-product serving costs about $0.38.
Price Per Serving Efficiency
The price is about $0.38 per whole-product serving.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
    Moon RJ; D' Angelo S; Curtis EM; Ward KA; Crozier SR; Schoenmakers I; Javaid MK; Bishop NJ; Godfrey KM; Cooper C; Harvey NC; MAVIDOS Trial Group · The American journal of clinical nutrition · 2024
    Randomized trial454 participantsBone Health forVitamin D
  2. Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
    Matsumoto T; Takano T; Saito H; Takahashi F · BoneKEy reports · 2014
    Narrative reviewBone Health forVitamin D
  3. Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: A systematic review and meta-analysis of interventional studies.
    Tangestani H; Djafarian K; Emamat H; Arabzadegan N; Shab-Bidar S · Critical reviews in food science and nutrition · 2020
    Meta-analysis1,786 participants20 studies pooledBone Health forVitamin D
  4. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
    Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Randomized trial193 participantsBone Health forVitamin D
  5. Vitamin D supplementation and bone health in post-menopausal women: a 24-month randomized controlled intervention with enhanced bioavailability formulations.
    Rasool N; Munir Y · European journal of clinical nutrition · 2026
    Randomized trial612 participantsBone Health forVitamin D
  6. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  7. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  8. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  9. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  10. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  11. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc.
    Elmståhl S; Gullberg B; Janzon L; Johnell O; Elmståhl B · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1999
    Cohort study6,576 participantsBone Health forZinc
  12. Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.
    Berger PK; Pollock NK; Laing EM; Chertin V; Bernard PJ; Grider A; Shapses SA; Ding KH; Isales CM; Lewis RD · The Journal of nutrition · 2016
    Randomized trial147 participantsBone Health forZinc
  13. Randomized controlled trial of prenatal zinc supplementation and fetal bone growth.
    Merialdi M; Caulfield LE; Zavaleta N; Figueroa A; Costigan KA; Dominici F; Dipietro JA · The American journal of clinical nutrition · 2004
    Randomized trial242 participantsBone Health forZinc
  14. The effects of zinc supplementation on serum zinc, alkaline phosphatase activity and fracture healing of bones.
    Sadighi A; Roshan MM; Moradi A; Ostadrahimi A · Saudi medical journal · 2009
    Randomized trial60 participantsBone Health forZinc
  15. Is Zinc an Important Trace Element on Bone-Related Diseases and Complications? A Meta-analysis and Systematic Review from Serum Level, Dietary Intake, and Supplementation Aspects.
    Ceylan MN; Akdas S; Yazihan N · Biological trace element research · 2021
    Meta-analysis40 studies pooledBone Health forZinc
  16. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support Heart Health forVitamin D
  17. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
    Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V · Journal of the American Society of Nephrology : JASN · 2017
    Randomized trial120 participantsCardiovascular Support forVitamin D
  18. Randomized, placebo-controlled, double-blind clinical trial on the contributions of vitamin D in the control of cardiovascular risk factors, depressive symptoms and suicide risk.
    Porto C; Petribu K; Barbosa N; Magalhães R; Lira C; Porto AB; Markman-Filho B; Lordsleem A; Calado E; Magalhães J; Sougey E; Silva T; Junio A; Bandeira F; Leão R · American heart journal plus : cardiology research and practice · 2025
    Randomized trial224 participantsCardiovascular Support forVitamin D
  19. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial.
    Raed A; Bhagatwala J; Zhu H; Pollock NK; Parikh SJ; Huang Y; Havens R; Kotak I; Guo DH; Dong Y · PloS one · 2017
    Randomized trial70 participantsCardiovascular Support forVitamin D
  20. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsCardiovascular Support Heart Health forVitamin D